Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta
Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta
Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta
Submitted by
admin
on July 2, 2013 - 9:38am
Source:
Street Insider
News Tags:
Roche
Genentech
FDA
Perjeta
breast cancer
Headline:
Roche's (RHHBY) Genentech Receives FDA Priority Review for Perjeta
Do Not Allow Advertisers to Use My Personal information
